AIM ImmunoTech Inc. has announced that its 2026 Annual Meeting of Stockholders has been adjourned without conducting any business. The meeting was originally convened on November 17, 2026, but was halted because the company did not have a sufficient number of shares present or represented by proxy to constitute a quorum.

A quorum would have been present if shares representing 33 and 1/3 percent of the outstanding common stock entitled to vote were present. At the time of the adjournment, proxies had been submitted representing approximately 32.5 percent of the outstanding shares, falling short of the required threshold.

The company stated that the adjournment was intended to provide stockholders with additional time to review the proxy materials and submit their votes. The meeting will reconvene on December 8, 2026, at 11:00 A.M. Eastern Time. The reconvened meeting will continue to be held in a virtual format, accessible via the link https://web.viewproxy.com/AIM/2026.

The record date for determining stockholders entitled to vote at the adjourned meeting remains the close of business on September 28, 2026. The company confirmed that no changes have been made to the proposals to be voted on by stockholders. Stockholders who have already submitted their proxy or voted do not need to take any further action.